Twice-Yearly Biologic Effective Against Nasal Polyps
(MedPage Today) -- SAN DIEGO -- Novel ultra-long-acting biologic depemokimab reduced nasal polyps in chronic rhinosinusitis, two parallel phase III ...
(MedPage Today) -- SAN DIEGO -- Novel ultra-long-acting biologic depemokimab reduced nasal polyps in chronic rhinosinusitis, two parallel phase III ...
(MedPage Today) -- "No one wants to lose their job. In the absence of any guidance, opinions fly about what ...
(MedPage Today) -- Obstructive sleep apnea (OSA) was linked with an increased risk of Parkinson's disease, but continuous positive airway ...
(MedPage Today) -- Dear Gerald Parker, DVM, PhD (Pandemic Czar), The threat of a widespread human outbreak of bird flu ...
(MedPage Today) -- President Donald Trump's plan to pull federal funding from institutions that provide gender-affirming care for transgender youth ...
(MedPage Today) -- SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing ...
(MedPage Today) -- Francis Collins, MD, PhD, a renowned geneticist and former longtime director of the NIH announced that he ...
PA MediaAmanda Pritchard, head of NHS England, would have regular Monday meetings with Health Secretary Wes Streeting to review performance ...
© 2022 NewsHealth.
© 2022 NewsHealth.